The messenger market is presently experiencing substantial growth, fueled by the triumphant deployment of mRNA-based immunizations against COVID-19. Studies suggest a evolving landscape, with ongoing investments into therapeutic applications beyond infectious diseases, including areas such as oncology, rare diseases, and protein replacement care… Read More